<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Tan LL</submitter><funding>Agency for Science, Technology and Research</funding><funding>Agency for Science, Technology and Research (A*STAR), Singapore</funding><funding>National Research Foundation</funding><funding>Singapore National Research Foundation (NRF)’s 19th Competitive Research Program</funding><pagination>486</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11048056</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(4)</volume><pubmed_abstract>In recent years, CRISPR-Cas toolboxes for &lt;i>Streptomyces&lt;/i> editing have rapidly accelerated natural product discovery and engineering. However, Cas efficiencies are oftentimes strain-dependent, and the commonly used &lt;i>Streptococcus pyogenes&lt;/i> Cas9 (SpCas9) is notorious for having high levels of off-target toxicity effects. Thus, a variety of Cas proteins is required for greater flexibility of genetic manipulation within a wider range of &lt;i>Streptomyces&lt;/i> strains. This study explored the first use of &lt;i>Acidaminococcus&lt;/i> sp. Cas12j, a hypercompact Cas12 subfamily, for genome editing in &lt;i>Streptomyces&lt;/i> and its potential in activating silent biosynthetic gene clusters (BGCs) to enhance natural product synthesis. While the editing efficiencies of Cas12j were not as high as previo</pubmed_abstract><journal>Biomolecules</journal><pubmed_title>Application of Cas12j for &lt;i>Streptomyces&lt;/i> Editing.</pubmed_title><pmcid>PMC11048056</pmcid><funding_grant_id>C211917003</funding_grant_id><funding_grant_id>NRF-CRP19-2017-05</funding_grant_id><funding_grant_id>C233017003</funding_grant_id><pubmed_authors>Yang LK</pubmed_authors><pubmed_authors>Kanagasundaram Y</pubmed_authors><pubmed_authors>Leong CY</pubmed_authors><pubmed_authors>Koduru L</pubmed_authors><pubmed_authors>Seow DCS</pubmed_authors><pubmed_authors>Heng E</pubmed_authors><pubmed_authors>Lim YH</pubmed_authors><pubmed_authors>Wong FT</pubmed_authors><pubmed_authors>Ng V</pubmed_authors><pubmed_authors>Ng SB</pubmed_authors><pubmed_authors>Peh G</pubmed_authors><pubmed_authors>Tan LL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Application of Cas12j for &lt;i>Streptomyces&lt;/i> Editing.</name><description>In recent years, CRISPR-Cas toolboxes for &lt;i>Streptomyces&lt;/i> editing have rapidly accelerated natural product discovery and engineering. However, Cas efficiencies are oftentimes strain-dependent, and the commonly used &lt;i>Streptococcus pyogenes&lt;/i> Cas9 (SpCas9) is notorious for having high levels of off-target toxicity effects. Thus, a variety of Cas proteins is required for greater flexibility of genetic manipulation within a wider range of &lt;i>Streptomyces&lt;/i> strains. This study explored the first use of &lt;i>Acidaminococcus&lt;/i> sp. Cas12j, a hypercompact Cas12 subfamily, for genome editing in &lt;i>Streptomyces&lt;/i> and its potential in activating silent biosynthetic gene clusters (BGCs) to enhance natural product synthesis. While the editing efficiencies of Cas12j were not as high as previo</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2026-04-08T19:48:03.508Z</modification><creation>2026-04-08T14:30:54.872Z</creation></dates><accession>S-EPMC11048056</accession><cross_references><pubmed>38672502</pubmed><doi>10.3390/biom14040486</doi></cross_references></HashMap>